Common Reverse Transcription Mistakes and Why Reverse Transcriptase (RTase) Choice Matters

Reverse transcription is frequently assumed to be straightforward. In practice, it is one of the most error-prone steps in RNA workflows. Small inefficiencies at this stage amplify downstream and can lead to misleading quantitative conclusions.

Below are some common mistakes and how to avoid them.

1. Using an RTase That Is Not Thermostable Enough

Many traditional reverse transcriptases operate optimally at 37°C to 42°C. At these temperatures, structured RNA regions remain folded, limiting enzyme access.

High GC regions and structured viral genomes are particularly affected.

Thermostable enzymes such as UltraScript® and UltraScript® 2.0 allow reactions up to 55°C and beyond, reducing secondary structure interference and improving transcript coverage.

2. Ignoring RNase H Activity

RNase H degrades RNA in RNA–DNA hybrids during reverse transcription. While some RNase H activity can improve second strand synthesis in cloning workflows, excessive activity can truncate transcripts prematurely.

UltraScript® 2.0 features reduced RNase H activity, supporting more complete first-strand synthesis, which is beneficial for sequencing and full-length transcript analysis.

3. Why not choose AMV-derived RTases?

Avian Myeloblastosis Virus, AMV, reverse transcriptase is sometimes selected because of its natural thermostability. However:

• AMV often has higher RNase H activity
• It may show lower fidelity compared to engineered MMLV variants
• It can produce shorter cDNA products in some contexts

Modern engineered MMLV-based RTases, such as UltraScript® and UltraScript® 2.0, often provide improved balance between thermostability, fidelity and transcript representation.

4. Overlooking Enzyme Concentration Effects on qPCR

Reverse transcriptases can inhibit downstream PCR if present in excess. High-activity enzymes may remain active after reverse transcription and interfere with polymerase performance.

With high-capacity enzymes such as UltraScript® 2.0, dilution of cDNA prior to qPCR improves Ct consistency. Consistent handling ensures reliable quantification.

5. Using a Single Priming Strategy for All Applications

Oligo(dT) priming targets polyadenylated mRNA but excludes non-polyadenylated RNA.

Random hexamers provide broader coverage but may introduce representation bias if not optimised.

Kits with balanced primer composition reduce handling variability. Separate oligo formats allow deliberate priming selection.

The optimal approach depends on whether the goal is:

• Targeted mRNA quantification
• Total RNA representation
• Viral RNA detection
• Transcriptome preparation

6. Not running the reaction long enough

We all want speed, right? A fast RTase is great and means the next step in a workflow will be carried out sooner. UltraScript® and UltraScript® 2.0 can both complete reactions in as little as 15 minutes. However, if working with particularly challenging samples, with difficult secondary structure, or very low RNA concentrations or low transcript abundance, increasing incubation time can really make a difference. Going from 15 to 30 minutes can produce significantly more cDNA, which is really useful for low-abundance transcripts or dilute samples.

Final Considerations

Reverse transcription is not interchangeable across enzymes. Differences in thermostability, RNase H activity, processivity and formulation directly affect experimental accuracy.

Selecting the correct RTase and the right cDNA synthesis conditions is not simply a specification choice. It is a data quality decision.

If you want to find out more about relevant cDNA Synthesis products reach out to info@pcrbio.com, or check out our quick Tips & Tricks.

Having trouble with your PCR Biosystems cDNA synthesis reagent? Get in touch with our technical team: technical@pcrbio.com.